The AD progression has been found to be correlated with cholinesterase activity levels such as: if the BChE level increases, then the AChE level decreases, ultimately resulting in the decrement of acetylcholine levels, leading to the loss of cognitive function [29]. This evidence concerns the gene BCHE and Alzheimer disease.